← Evidence map

ArticleFuture medicinal chemistry2025

Enhancing thiazolide efficacy: C-4 aryl modifications drive selective SARS-CoV-2 inhibition.

Rizwan Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40948423